Breast cancer and oral contraceptive use in Asian-American women

American Journal of Epidemiology

Volumn 150, Issue 6, 1999, Pages 561-567

  Ursin, Giske ^a   Wu, Anna H ^a   Hoover, Robert N ^b   West, Dee W ^c   Nomura, Abraham M Y ^d   Kolonel, Laurence N ^d   Pike, Malcolm C ^a   Ziegler, Regina G ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NORTHERN CALIFORNIA CANCER CENTER   (United States)

^d UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Asian Americans; Breast neoplasms; Contraceptives, oral; Transients and migrants

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

CANCER; CONTRACEPTIVE USE; DISEASE PREVALENCE; ETHNICITY; MEDICAL GEOGRAPHY;

ADULT; ARTICLE; ASIAN AMERICAN; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; EDUCATION; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MIGRATION; ORAL CONTRACEPTION; UNITED STATES;

UNITED STATES;

EID: 0033568791     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a010053     Document Type: Article

References (46)

1. Doll R, Payne P, Waterhouse J, eds. Cancer incidence in five continents. Vol I. UICC Technical Report. New York: Springer Verlag, 1966.
2. Ursin G, Bernstein L, Pike MC. Breast cancer. Cancer Surveys 1994;19/20:241-64.
3. Ziegler RG, Hoover RN, Pike MC et al. Migration patterns and breast cancer risk in Asian American women. J Natl Cancer Inst 1993;85:1819-27.
4. Kolonel LN, Hinds MW, Hankin JH. Cancer patterns among migrant and native-born Japanese in Hawaii in relation to smoking, drinking, and dietary habits. In: Gelboin HV, MacMahon B, Matsushima T, et al, eds. Genetic and environmental factors in experimental and human cancer. Tokyo: Japan Sei Soc Press, 1980:327-40.
5. Olsson H. Oral contraceptives and breast cancer: a review. Acta Oncol 1989;28:849-63.
6. Schlesselman JJ. Oral contraceptives and breast cancer. Am J Obstet Gynecol 1990;163:1379-87.
7. Romieu I, Berlin JA, Colditz G. Oral contraceptives and breast cancer. Review and meta-analysis. Cancer 1990;66:2253-63.
8. Harlap. Oral contraceptives and breast cancer. Cause and effect? J Reprod Med 1991;36:374-95.
9. Thomas DB. Oral contraceptives and breast cancer: review of the epidemiologic literature. Contraception 1991;43:597-642.
10. Malone KE, Daling JR, Weiss NS. Oral contraceptives in relation to breast cancer. Epidemiol Rev 1993;15:80-97.
11. Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. Oral-contraceptive use and the risk of breast cancer. N Engl J Med 1986;315:405-11.
12. Meirik O, Lund E, Adami H-O, et al. Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway. Lancet 1986;2:650-4.
13. McPherson K, Vessey MP, Neil A, et al. Early oral contraceptive use and breast cancer: results of another case-control study. Br J Cancer 1987;56:653-60.
14. Ravnihar B, Zakelj MP, Kosmelj K, et al. A case-control study of breast cancer in relation to oral contraceptive use in Slovenia. Neoplasma 1988;35:109-21.
15. Miller DR, Rosenberg L, Kaufman DW, et al. Breast cancer before age 45 and oral contraceptive use: new findings. Am J Epidemiol 1989;129:269-80.
16. UK National Case-Control Study Group. Oral contraceptive use and breast cancer risk in young women. Lancet 1989;1: 973-82.
17. Paul C, Skegg DC, Spears GF. Oral contraceptives and risk of breast cancer. Int J Cancer 1990;46:366-73.
18. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Breast cancer and combined oral contraceptives: results from a multinational study. Br J Cancer 1990;61: 110-19.
19. Rookus MA, van Leeuwen FE for the Netherlands Oral Contraceptives and Breast Cancer Study Group. Oral contraceptives and risk of breast cancer in women aged 20-54 years. Lancet 1994;344:844-51.
20. White E, Malone KE, Weiss NS, et al. Breast cancer among young US women in relation to oral contraceptive use. J Natl Cancer Inst 1994;86:505-14.
21. Brinton LA, Daling JR, Liff JM, et al. Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst 1995;87:827-35.
22. Rosenberg L, Palmer JR, Rao S, et al. Case-control study of oral contraceptive use and risk of breast cancer. Am J Epidemiol 1996;143:25-37.
23. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 1996;347:1713-27.
24. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: further results. Contraception 1996;54(suppl):1-106.
25. Wharton C, Blackburn R. Lower-dose pills. Population Reports, Series A, No. 7. Baltimore, MD: Johns Hopkins School of Public Health, Population Information Program, November 1988.
26. Ogawa N, Retherford RD. Prospects for increased contraceptive pill use in Japan. Stud Fam Plann 1991;22:378-83.
27. Breslow NE, Day NE. Statistical methods in cancer research. Vol 1. The analysis of case-control studies. (IARC scientific publications no. 32). Lyon: International Agency for Research on Cancer, 1980.
28. Ziegler RG, Hoover RN, Nomura AMY, et al. Relative weight, weight change, height and breast cancer risk in Asian American women. J Natl Cancer Inst 1996;88:650-60.
29. Wu AH, Ziegler RG, Pike MC, et al. Menstrual and reproductive factors and risk of breast cancer in Asian-Americans. Br J Cancer 1996;73:680-6.
30. Wu AH, Ziegler RG, Horn-Ross PL, et al. Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol Biomarkers Prev 1996;5:901-6.
31. Pike MC, Henderson BE, Casagrande JT, et al. Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer 1981;43:72-6.
32. Pike MC, Henderson BE, Krailo MD, et al. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet 1983;2: 926-30.
33. Bernstein L, Pike MC, Krailo M, et al. Update of the Los Angeles Study of Oral Contraceptives and Breast Cancer: 1981 and 1983. In: Mann RD, ed. Oral contraceptives and breast cancer: the implications of the present findings for informed consent and informed choice. Park Ridge, NJ: Parthenon Publishing Group, 1990:169-80.
34. Ursin G, Ross RK, Sullivan-Halley J, et al. Oral contraceptive use and breast cancer risk in women aged 40 years or younger. (Abstract). Am J Epidemiol 1996;143:543.
35. Yuan JM, Yu MC, Ross RK, et al. Risk factors for breast cancer in Chinese women in Shanghai. Cancer Res 1988;48:1949-53.
36. Wang QS, Ross RK, Yu MC, et al. A case-control study of breast cancer in Tianjin, China. Cancer Epidemiol Biomarkers Prev 1992;1:435-9.
37. Lee HP, Gourley L, Duffy SW, et al. Risk factors for breast cancer by age and menopausal status: a case-control study in Singapore. Cancer Causes Control 1992;3:313-22.
38. Bernstein L, Yuan JM, Ross RK, et al. Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer case-control studies. Cancer Causes Control 1990;1:51-8.
39. Shimizu H, Ross RK, Bernstein L, et al. Serum estrogen levels in post-menopausal women: comparison of American whites and Japanese in Japan. Br J Cancer 1990;62:451-3.
40. Trichopolous D, Yen S, Brown J, et al. The effect of Westernization on urine estrogens, frequency of ovulation and breast cancer risk. Cancer 1984;53:187-92.
41. Pike MC, Spicer DV, Dahmoush L, et al. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993;15:17-35.
42. Meyer JS. Cell proliferation in normal human breast ducts, fibroadenoma, and other duct hyperplasias, measured by nuclear labeling with tritiated thymidine. Hum Pathol 1977;8:67-81.
43. Anderson TJ, Battersby S, King RJB, et al. Oral contraceptive use influences resting breast proliferation. Hum Pathol 1989;20:1139-44.
44. Williams G, Anderson E, Howell A, et al. Oral contraceptive (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast. Int J Cancer 1991;48:206-10.
45. Olsson H, Jernström H, Alm P, et al. Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factors. Breast Cancer Res Treat 1996;40:187-96.
46. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Breast cancer and combined oral contraceptives: results from a multinational study. Br J Cancer 1990;61:110-19.